The Journal of Urology
Volume 177, Issue 3 , Pages 1040-1046 , March 2007

A Temporary Intraurethral Prostatic Stent Relieves Prostatic Obstruction Following Transurethral Microwave Thermotherapy

  • Neal D. Shore

      Affiliations

    • Grand Strand Urology, Myrtle Beach, South Carolina
    • Corresponding Author InformationCorrespondence: 823 82nd Parkway, Myrtle Beach, South Carolina 29572 (telephone: 843-449-1010; FAX: 843-286-0119).
    • Financial interest and/or other relationship with AbbeyMoor Medical, Inc., Dendreon, Boston Scientific and Oncura.
    • ,
  • Martin K. Dineen

      Affiliations

    • Atlantic Urology Associates, Daytona Beach, Florida
    • Financial interest and/or other relationship with Endocare, AbbeyMoor Medical, Inc., Mentor, Sanofi, Genomics, QLT, AstraZeneca, GlaxoSmithKline, GTX, Amgen, National Cancer Institute-Johns Hopkins, Nymox, Schering-Plough.
    • ,
  • Mark J. Saslawsky

      Affiliations

    • Southeast Urology Network, Memphis, Tennessee
    • Financial interest and/or other relationship with AbbeyMoor Medical, Inc.
    • ,
  • Jeffrey H. Lumerman

      Affiliations

    • Urological Surgeons of Long Island, Garden City, New York
    • ,
  • Alberto P. Corica

      Affiliations

    • Instituto Urologico De Guayama, Guayama, Puerto Rico
    • Financial interest and/or other relationship with AbbeyMoor Medical, Inc.

Received 8 July 2006

References 

  1. Roehrborn CG, McConnell JD. Etiology, pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. In:  Walsh PC,  Retik AB,  Vaughan ED,  Wein AJ editor. Campbell’s Urology. Philadelphia: WB Saunders Co; 2002;p. 1309;chapt 38
  2. Larson TR, Blute ML, Bruskewitz RC, Mayer RD, Ugarte RR, Utz WJ. A high-efficiency microwave thermoablation system for the treatment of benign prostatic hyperplasia: results of a randomized, sham-controlled, prospective, double-blind, multicenter clinical trial. Urology. 1998;51:731
  3. D’Ancona FC, Francisca EA, Witjes WP, Welling L, Debruyne FM, delaRosette JJ. Transurethral resection of the prostate vs. high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: long-term results. Br J Urol. 1998;81:259
  4. Wagrell L, Schelin S, Nordling J, Richthoff J, Magnusson B, Schain M, et al. Feedback microwave thermotherapy versus TURP for clinical BPH—a randomized controlled multicenter study. Urology. 2002;60:292
  5. Floratos DL, Kiemeney LA, Rossi C, Kortmann BB, Debruyne FM, de La Rosette JJ. Long-term followup of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study. J Urol. 2001;165:1533
  6. de la Rosette JJ, de Wildt MJ, Höfner K, Carter SS, Debruyne FM, Tubaro A. High energy thermotherapy in the treatment of benign prostatic hyperplasia: results of the European benign prostatic hyperplasia study group. J Urol. 1996;156:97
  7. Roehrborn CG, Preminger G, Newhall P, Denstedt J, Razvi H, Chin LJ, et al. Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: results of a randomized, double-blind, multicenter, sham-controlled trial. Urology. 1998;51:19
  8. Djavan B, Fakhari M, Shariat S, Ghawidel K, Marberger M. A novel intraurethral prostatic bridge catheter for prevention of temporary prostatic obstruction following high energy transurethral microwave thermotherapy in patients with benign prostatic hyperplasia. J Urol. 1999;161:144
  9. Kapoor R, Lai RS, Liatsikos EN, Dinlenc CZ, Badlani GH. Do prostatic stents solve the problem of retention after transurethral microwave therapy. J Endourol. 2000;14:683
  10. Ogiste JS, Cooper K, Kaplan SA. Are stents still a useful therapy for benign prostate hyperplasia?. Curr Opin Urol. 2003;13:51
  11. Devonec M, Dahlstrand C. Temporary urethral stenting after high-energy transurethral microwave thermotherapy of the prostate. World J Urol. 1998;16:120
  12. Corica AP, Larson BT, Sagaz A, Corica AG, Larson TR. A novel temporary prostatic stent for the relief of prostatic urethral obstruction. BJU Int. 2004;93:346
  13. Dahlstrand C, Grundtman S, Pettersson S. High-energy transurethral microwave thermotherapy for large severely obstructing prostates and the use of biodegradable stents to avoid catheterization after treatment. Br J Urol. 1997;79:907
  14. Henderson A, Laing RW, Langley SEM. A Spanner™ in the works; the new use of a temporary urethral stent to relieve bladder outflow obstruction after prostate brachytherapy. Brachytherapy. 2002;1:211
  15. Yalla SV. How to use urodynamics to assess voiding dysfunction: urodynamic tests should be tailored to an individual patient’s suspected dysfunction. Advanstar Communications. Urol Times. 2002;September
  16. Abrams P, Blaivas J, Nordling J, Griffiths DJ, Kondo A, Kayanagi T, et al. The objective evaluation of bladder outflow obstruction. In:  Cockett ATK,  Khoury S,  Aso Y,  Chatelain C,  Denis L,  Griffiths K, et al. editor. The 2nd International Consultation of Benign Prostatic Hyperplasia (BPH). Jersey, Channel Islands: Scientific Communication International Ltd; 1993;p. 179;chapt 6
  17. Barry MJ, Williford WO, Chang Y, Machi M, Jones KM, Walker-Corkery E, et al. Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index and the benign prostatic hyperplasia impact index is perceptible to patients?. J Urol. 1995;154:1770
  18. Egilmez T, Aridogan IA, Yachia D, Hassin D. Comparison of nitinol urethral stent infections with indwelling catheter-associated urinary-tract infections. J Endourol. 2006;20:272
  19. Thomas AW, Abrams P. Lower urinary tract symptoms, benign prostatic obstruction and the overactive bladder. BJU Int. 2000;85:57

PII: S0022-5347(06)02741-8

doi: 10.1016/j.juro.2006.10.059

The Journal of Urology
Volume 177, Issue 3 , Pages 1040-1046 , March 2007

Article Tools

* Image Usage & Resolution